Cours Sawai Pharmaceutical Co., Ltd. Japan Exchange
Actions
4555
JP3323050009
Produits pharmaceutiques
CA 2024 * | 194 Md 1,22 Md 1,12 Md | CA 2025 * | 203 Md 1,28 Md 1,17 Md | Capitalisation | 261 Md 1,65 Md 1,51 Md |
---|---|---|---|---|---|
Résultat net 2024 * | 19,79 Md 125 M 114 M | Résultat net 2025 * | 19,91 Md 126 M 115 M | VE / CA 2024 * | 1,53 x |
Dette nette 2024 * | 34,69 Md 219 M 200 M | Dette nette 2025 * | 39,72 Md 251 M 229 M | VE / CA 2025 * | 1,48 x |
PER 2024 * |
13,2
x | PER 2025 * |
13,1
x | Employés | 3 393 |
Rendement 2024 * |
2,18% | Rendement 2025 * |
2,31% | Flottant | 0% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Mitsuo Sawai
CEO | Chief Executive Officer | 67 | 01/04/21 |
President | 66 | 01/04/21 | |
Toru Terashima
BRD | Director/Board Member | 64 | 01/04/21 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Mitsuo Sawai
CEO | Chief Executive Officer | 67 | 01/04/21 |
Kenzo Sawai
BRD | Director/Board Member | 55 | 01/04/21 |
Masatoshi Ohara
BRD | Director/Board Member | 73 | 01/04/21 |
Varia. 1 janv. | Capi. | |
---|---|---|
+25,83% | 661 Md | |
+27,00% | 566 Md | |
-6,76% | 352 Md | |
+20,34% | 332 Md | |
+3,00% | 283 Md | |
+13,09% | 231 Md | |
+5,46% | 200 Md | |
-9,61% | 195 Md | |
-6,26% | 145 Md |